z-logo
open-access-imgOpen Access
Comparative efficacy and safety of pharmacological interventions for severe COVID-19 patients: An updated network meta-analysis of 48 randomized controlled trials
Author(s) -
Qinglin Cheng,
Gang Zhao,
Chen Jun-fang,
Qingjun Jia,
Zijian Fang
Publication year - 2022
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000030998
Subject(s) - medicine , randomized controlled trial , lopinavir , adverse effect , methylprednisolone , ritonavir , placebo , hydroxychloroquine , tocilizumab , viral load , covid-19 , immunology , rheumatoid arthritis , human immunodeficiency virus (hiv) , alternative medicine , disease , pathology , antiretroviral therapy , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here